ليست عنوان مقالات لاتين Cardiac Complications of Thoracic Irradiation Cardiomyopathy in neurological disorders

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Cardiac Complications of Thoracic Irradiation

2

Cardiac complications of vaccines

3

Cardiac complications with vertically transmitted HIV infection

4

Cardiac compression by a thymic cyst

5

Cardiac Compression Devices: Alternative Technology and Innovative Concept

6

Cardiac compression of a hepatic cyst in polycystic liver disease: A rare cause of hemodynamic instability

7

Cardiac compromise in a patient with Downʹs Syndrome: a lesson learnt

8

Cardiac Computed Tomographic Angiography: Whatʹs the Prognosis?

9

Cardiac computed tomography and radiation

10

Cardiac concomitants of performance monitoring: Context dependence and individual differences

11

Cardiac conduction abnormalities in endocarditis defined by the Duke criteria

12

Cardiac Conduction Disorders in Children with Community-Acquired Pneumonia

13

Cardiac conduction disturbances after an overdose of nefazodone and gabapentin

14

Cardiac Conduction Disturbances Seen After Transcatheter Device Closure of Muscular Ventricular Septal Defects With the Amplatzer Occluder

15

Cardiac conduction system involvement in sudden death of obese young people

16

Cardiac Consequences of Aldosterone Excess In Human Hypertension

17

Cardiac consequences of malnutrition—ancel keys revisited!

18

Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

19

Cardiac Contractility Modulation Electrical Signals Improve Myocardial Gene Expression in Patients With Heart Failure Original Research Article

20

Cardiac Contraction Motion Correction in Gated Myocardial Perfusion SPECT Projection Domain

21

Cardiac contusion as a primary clinical entity

22

Cardiac contusion: Ending myocardial confusion in this capricious syndrome

23

Cardiac CT Angiography of a Membranous Ventricular Septal Aneurysm Short Title: Ventricular Septal Aneurysm

24

Cardiac CT in Mixed Type Atrial Septum Defects

25

Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance

26

Cardiac cytoarchitecture and myofibril attachment during development and disease

27

Cardiac cytokine expression after myocardial infarction in rats

28

Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study

29

Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators

30

Cardiac death—current concepts

31

Cardiac Dedifferentiated Liposarcoma Requiring a Mitral Valve Replacement Complicated by Severe Paravalvular Leak: A Rare Case Report with Literature Review

32

Cardiac delayed enhancement distribution in extralysosomial glycogen storage disease

33

Cardiac Deletion of the Coxsackievirus-Adenovirus Receptor Abolishes Coxsackievirus B3 Infection and Prevents Myocarditis In Vivo

34

Cardiac Denervation After Radiofrequency Ablation of Supraventricular Tachycardias

35

Cardiac denervation in amyloid polyneuropathy

36

Cardiac depression scale: Validation of a new depression scale for cardiac patients

37

Cardiac Differentiation of Adipose Tissue-Derived Stem Cells Is Driven by BMP4 and bFGF but Counteracted by 5-Azacytidine and Valproic Acid

38

Cardiac differentiation of cardiosphere-derived cells in scaffolds mimicking morphology of the cardiac extracellular matrix

39

Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age

40

Cardiac disease after chest irradiation for Hodgkinʹs disease: incidence in 108 patients with long follow-up

41

Cardiac disease and risk of sudden death in the young: the burden of the phenomenon

42

Cardiac disease construction on the borderland

43

Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

44

Cardiac disease in pregnancy—A.I.I.M.S. experience

45

Cardiac disease, anxiety, and sexual functioning

46

Cardiac Disorder in an Iranian Child With Hepatitis A Virus

47

Cardiac disorders and mode of action of the Egyptian scorpion venom Androctonus bicolor on isolated toad’s heart

48

Cardiac drug-psychotropic drug update

49

Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer

50

Cardiac dysfunction after burns

51

Cardiac dysfunction and abnormal responses to hemodynamic stress in mice lacking s100a1 protein

52

Cardiac Dysfunction and Serum Ferritin Level as Early Prognostic Markers in Children with Sepsis: A Cross-sectional Study

53

Cardiac Dysfunction in a Child with Severe Multisystem Inflammatory Syndrome

54

Cardiac dysfunction in cirrhosis

55

Cardiac dysfunction in human immunodeficiency virus (HIV) infected patients in India

56

Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis

57

Cardiac dysfunction is attenuated by ginkgolide B via reducing oxidative stress and fibrosis in diabetic rats

58

Cardiac dysfunction with Becker muscular dystrophy

59

Cardiac dysrhythmia in COVID-19 patients; occurrence and risk factors: a retrospective cohort study

60

Cardiac Dysrhythmias and Neurological Dysregulation: Manifestations of Profound Hypomagnesemia

61

Cardiac Dyssynchrony in Congestive Heart Failure and Atrial Fibrillation: Integrating Regularization and Resynchronization

62

Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy

63

Cardiac echinococcosis causing coronary artery disease

64

Cardiac Echinococcosis: Surgical Treatment and Results in 10 Cases

65

Cardiac effects of acute myelitis

66

Cardiac Effects of Antiretroviral Therapy in HIV-Negative Infants Born to HIV-Positive Mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children Cohort Study)

67

Cardiac Effects of Calcium Antagonists in Systemic Hypertension

68

Cardiac effects of exercise rehabilitation in hemodialysis patients

69

Cardiac effects of l-thyroxine administration in borderline hypothyroidism

70

Cardiac electrophysiologic effects of norepinephrine in human beings, ,

71

Cardiac Electrophysiological Consequences of Neuromuscular Incapacitating Device Discharges Original Research Article

72

Cardiac electrophysiological effects of ETA & ETB receptor stimulation in isolated working rabbit hearts

73

Cardiac Electrophysiology Studies and Ablations for Treatment of Supraventricular Arrhythmias — An Initial Experience from Karachi

74

Cardiac electrophysiology: keeping in rhythm

75

Cardiac Ellis–van Creveld syndrome

76

Cardiac encasement by metastatic myxoid liposarcoma

77

Cardiac energy metabolism alterations in angiotensin II induced hypertrophy

78

Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats

79

Cardiac Energy Metabolism Homeostasis: Role of Cytosolic Calcium

80

Cardiac energy metabolism in patients with chest pain and normal coronary angiograms

81

Cardiac Entrapment During Minimally Invasive Aortic Valve Replacement

82

Cardiac enzyme (troponin levels) elevation in cardiac myxomas: Is it real?

83

Cardiac enzyme elevations after cardiac surgery: The cardiologistʹs perspective

84

Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality

85

Cardiac enzyme in emergency medicine

86

Cardiac enzymes and autotransfusion of shed mediastinal blood after myocardial revascularization

87

Cardiac epithelioid hemangioendothelioma with 8-year follow-up

88

CARDIAC EVALUATION OF PATIENTS WITH ISCHEMIC STROKE

89

Cardiac Event Rates After Acute Myocardial Infarction in Patients Treated With Verapamil and Trandolapril Versus Trandolapril Alone

90

Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: Importance of resting wall motion abnormalities Original Research Article

91

Cardiac Excrescences of Unusual Origin

92

Cardiac Expression and Subcellular Localization of the p38 Mitogen-activated Protein Kinase Member, Stress-activated Protein Kinase-3 (SAPK3)

93

Cardiac expression of glucocorticoid receptor α in mice

94

Cardiac expression of ID1 and ID3 is stimulated by chronic ischemia

95

Cardiac Expression of Placental Growth Factor Predicts the Improvement of Chronic Phase Left Ventricular Function in Patients With Acute Myocardial Infarction Original Research Article

96

Cardiac Expression of Sarcolipin Calpain After Immobilization Stress in Young Old Female Rats, Role of Alpha Beta Adrenoceptor Blockers

97

Cardiac extrinsic neuropathy: Lesions of the mediastinal paraganglia in chronic chagasic cardiomyopathy

98

Cardiac factors affecting the success of vardenafil in erectile dysfunction

99

Cardiac fatigue and oxygen kinetics after prolonged exercise

100

Cardiac Fibroblasts: Form and Function

101

Cardiac Fibroelastoma versus Thrombus: Echocardiographic Evidence Can Be Misleading

102

Cardiac Fibroma

103

Cardiac Fibroma in a Neonate Presenting With Dyspnea and Tachycardia: A Very Rare Case

104

Cardiac fibroma in an infant: single ventricle palliation as a bridge to heart transplantation

105

Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude

106

Cardiac Fibrosis in Human Transplanted Hearts Is Mainly Driven by Cells of Intracardiac Origin

107

Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II

108

Cardiac Findings After Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

109

Cardiac Findings in Congenital Nephrotic Syndrome

110

Cardiac flow component analysis

111

Cardiac function and heart failure

112

Cardiac Function and Heart Failure Review Article

113

Cardiac Function and Heart Failure Review Article

114

Cardiac Function and Position More Than 5 Years After Pneumonectomy

115

Cardiac function at rest in hypothyroidism evaluated by equilibrium radionuclide angiography

116

Cardiac Function Before and After Surgery for Pectus Excavatum

117

Cardiac Function Before and After Surgery for Pectus Excavatum

118

Cardiac function during mild hypothermia in human-sized pigs: Increased inotropy at the cost of diastolic dysfunction

119

Cardiac function estimation from MRI using a heart model and data assimilation: Advances and difficulties

120

Cardiac Function in Brain Death, Usage of Advanced Hemodynamic Monitoring

121

Cardiac function in smokers and nonsmokers: The CARDI study

122

Cardiac Function Modeling in Patients With Acute Myocardial Infarction Based on Type D Personality Considering the Mediating Role of Health-Promoting Lifestyle

123

Cardiac glycosides could protect brain cells from stroke

124

Cardiac hemangioendothelioma

125

Cardiac Hemangioma

126

Cardiac Hemangioma: A Benign Tumor with Different Morphological Appearances

127

Cardiac hemochromatosis

128

Cardiac Hemodynamic and Coronary Angiographic Characteristics of Patients Being Evaluated for Liver Transplantation

129

Cardiac Hemodynamics in Men Versus Women During Acute ST-Segment Elevation Myocardial Infarction

130

Cardiac Hemosiderosis in Transfusion DependentThalassemia: A Mini-Review

131

Cardiac Hepatopathy Versus End-Stage Liver Disease: Two Different Entities

132

Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome

133

Cardiac hormone: predictive of prognosis

134

Cardiac hydatid cyst located in the interventricular septum

135

Cardiac Hydatid Cyst without Liver Involvement: A Case Re-port

136

Cardiac Hydatid Cyst: A Case Report

137

Cardiac Hydatid Cyst: A Case Report

138

Cardiac hydatid cyst: A rare presentation of echinococcal infection

139

Cardiac Hydatid Cyst: An Unusual Cause of Chest Pain

140

Cardiac hydatid cysts

141

Cardiac hydatid cysts with intracavitary expansion

142

Cardiac hydatid cysts: Reply

143

Cardiac hydatidosis : A rare infection of the heart with hydatid cyst of Echinococcus granulosus can produced anaemia

144

Cardiac Hypertrophy Alters Expression of Na+,K+-ATPase Subunit Isoforms at mRNA and Protein Levels in Rat Myocardium

145

Cardiac Hypertrophy Due to Hydrocortisone Treatment in a Preterm Infant: A Case Report

146

Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1

147

Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings

148

Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness

149

Cardiac hypertrophy in the Dahl rat is associated with increased tyrosine phosphorylation of several cytosolic proteins, including a 120 kDa protein

150

Cardiac hypertrophy in the prague hypertensive rat (PHR) is associated with enhanced JNK2 but not ERK tissue activity

151

Cardiac IK1 underlies early action potential shortening during hypoxia in the mouse heart

152

Cardiac imaging

153

Cardiac imaging

154

Cardiac Imaging in FIP1L1-PDGFRA

155

Cardiac Imaging in Patients With Chronic Obstructive Pulmonary Disease and Chronic Heart Failure

156

Cardiac imaging in the evaluation of mitral annulus caseous calcification

157

Cardiac Imaging Integration in 2009 and Beyond

158

Cardiac Imaging Integration in 2009 and Beyond: Cardiovascular magnetic resonance

159

Cardiac Imaging Secrets: Neil J. Weissman and Gabriel A. Adelmann, Eds., Philadelphia, PA: Hanley and Belfus, 2003, 350 pages, 100 illustrations, US$36.95.

160

Cardiac imaging using optison

161

Cardiac imaging—the requisites, 2nd edition. Stephen Wilmot Miller (Ed). Philadelphia, PA: Mosby, imprint of Elsevier Science, 2004, 464 pages, 894 illustrations (US$99.00).

162

Cardiac immunocyte-derived (AL) amyloidosis: An endomyocardial biopsy study in 11 patients

163

Cardiac implications of Lyme disease, diagnosis and therapeutic approach

164

Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: Relation to arising time

165

Cardiac index quantification by Doppler ultrasound in patients without left ventricular outflow tract abnormalities

166

Cardiac infections: focus on molecular diagnosis

167

Cardiac Infertility in Persian Medicine: Avicenna’s View

168

Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats

169

Cardiac inhibitory response to alpha stimulation is blunted in young patients with essential hypertension.

170

Cardiac Injuries: A Review of Multidetector Computed Tomography Findings

171

Cardiac injury by a nail gun

172

Cardiac Injury by Activated Leukocytes: Effect of Cyclooxygenase and Lipoxygenase Inhibition Evaluated by Electron Microscopical Morphometry

173

Cardiac instrument development in a low-literacy population: The revised Chest Discomfort Diary

174

Cardiac Integrins: The Ties That Bind

175

Cardiac Intensivism: A View From a Fellow-in-Training

176

Cardiac intracavitary metastasis of a malignant solitary fibrous tumor: case report and review of the literature on sarcomas with left intracavitary extension

177

Cardiac involvement according to echocardiographic findings in severe coronavirus disease 2019

178

Cardiac Involvement and Echocardiographic Characteristics in Rheumatoid Arthritis

179

Cardiac Involvement and Subsequent Death due to Extranodal NK/T Cell Cutaneous T-Cell Lymphoma: An Autopsy Case and Brief Review of the Literature

180

Cardiac involvement in a case of acute lymphoblastic leukemia

181

Cardiac Involvement in a Fetus With Vein of Galen Aneurysmal Malformation, Diagnosis, and Treatment: A Case Report

182

Cardiac Involvement in a Patient with Eosinophilia and Inversion of Chromosome 16(p13q22): A Case of Chronic Eosinophilic Leukemia or AML-M4EO?

183

Cardiac Involvement in Adults With m.3243A>G MELAS Gene Mutation

184

Cardiac involvement in childhood polyarteritis nodosa

185

Cardiac involvement in Dengue Haemorrhagic Fever

186

Cardiac Involvement in Lysosomal Diseases

187

Cardiac Involvement in Mild Cystic Fibrosis Lung Involvement Assessed by Tissue‐Doppler Echocardiography

188

Cardiac Involvement in Non-Hodgkin Lymphoma, an Incidental Large Atrial Mass: A Case Report

189

Cardiac Involvement in Non-Hodgkin Lymphoma, an Incidental Large Atrial Mass: A Case Report

190

Cardiac Involvement in Systemic Lupus Erythematosus: Echocardiographic Evaluation

191

Cardiac involvement in systemic rheumatic diseases: An update

192

Cardiac Involvement in the Churg-Strauss Syndrome

193

Cardiac Involvement in Von Hippel-Lindau Disease

194

Cardiac involvement in Wegener granulomatosis diagnosed at autopsy

195

Cardiac involvement is a constant finding in acute Chagasʹ disease: a clinical, parasitological and histopathological study

196

Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder

197

Cardiac Involvement with Diffuse Large B Cell Lymphoma

198

Cardiac Involvements in Patients with Celiac Disease by Doppler Tissue Echocardiography Compared to Conventional Echocardiography

199

Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Sudden Cardiac Death Independently of Left Ventricular Ejection Fraction in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results From a Comparative Study With Si

200

Cardiac ion channel expression and regulation: the role of innervation

201

Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity

202

Cardiac ion channels and channelopathies

203

Cardiac ischemia/reperfusion, aging, and redox-dependent alterations in mitochondrial function

204

Cardiac ischemic preconditioning improves lung preservation in valve replacement operations

205

Cardiac isoform of alpha-2 macroglobulin—A new biomarker for myocardial infarcted diabetic patients

206

Cardiac issues related to trastuzumab

207

Cardiac KATP channels in health and disease

208

Cardiac Lipoma: An Uncharacteristically Large Intra-Atrial Mass Causing Symptoms

209

Cardiac Luxation to Facilitate Off-Pump Bilateral Lung Transplantation

210

Cardiac Lymphoma Following Mitral Valve Replacement

211

Cardiac Magnetic Resonance and the Need for Routine Cardiac Catheterization in Single Ventricle Patients Prior to Fontan: A Comparison of 3 Groups: Pre-Fontan CMR Versus Cath Evaluation

212

Cardiac Magnetic Resonance Detection of Myocardial Scarring in Hypertrophic Cardiomyopathy: Correlation With Histopathology and Prevalence of Ventricular Tachycardia

213

Cardiac magnetic resonance documentation of a double atrial septal defect before and after percutaneous closure with an Amplatzer septal occluder

214

Cardiac Magnetic Resonance Evaluation of the Impact of Interventricular and Intraventricular Dyssynchrony on Cardiac Ventricular Systolic and Diastolic Function in Patients With Isolated Left Bundle Branch Block

215

Cardiac Magnetic Resonance Findings in Congenitally Absent Pericardium

216

Cardiac Magnetic Resonance for Diagnosis of Neuroendocrine Tumor Metastases to the Right and Left Ventricles with Carcinoid Heart Disease

217

Cardiac Magnetic Resonance for Risk Stratification of Patients With Frequent Premature Ventricular Contractions

218

Cardiac magnetic resonance imaging and core cardiology training II (COCATS-2): Can we get there from here?

219

Cardiac Magnetic Resonance Imaging and Coronary Computed Tomography Angiography in the Diagnosis of Anomalous Coronary Artery

220

Cardiac Magnetic Resonance Imaging and the Assessment of Ebstein Anomaly in Adults

221

Cardiac Magnetic Resonance Imaging and the WATCHMAN Device

222

Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiography in Patients With Transcatheter Closure of Patent Foramen Ovale Original Research Article

223

Cardiac Magnetic Resonance Imaging Correlates of Exercise Capacity in Patients With Surgically Repaired Tetralogy of Fallot

224

Cardiac Magnetic Resonance Imaging Findings and the Risk of Cardiovascular Events in Patients With Recent Myocardial Infarction or Suspected or Known Coronary Artery Disease: A Systematic Review of Prognostic Studies

225

Cardiac Magnetic Resonance Imaging Findings in a Patient with Ebstein’s Anomaly and Left Ventricular Dysfunction

226

Cardiac magnetic resonance imaging findings in a patient with noncompaction of ventricular myocardium

227

Cardiac Magnetic Resonance Imaging for Accurate Diagnosis of Aortic Arch Anomalies in Patients with 22q11.2 Deletion

228

Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis

229

Cardiac Magnetic Resonance Imaging Identification of Myocardial Fibrosis: The Need for Standardization and Therapies

230

Cardiac magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy: correlation to the QRS dispersion

231

Cardiac magnetic resonance imaging in small animal models of human heart failure

232

Cardiac magnetic resonance imaging in the diagnosis of myocarditis mimicking myocardial infarction

233

Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer

234

Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease

235

Cardiac magnetic resonance imaging of systemic amyloidosis patients with normal left ventricular ejection fraction: An initial study

236

Cardiac Magnetic Resonance Imaging Signal Characteristics of Cardiac Tumors in Children

237

Cardiac Magnetic Resonance Imaging Study for Quantification of Infarct Size Comparing Directly Serial Versus Single Time-Point Measurements of Cardiac Troponin T Original Research Article

238

Cardiac magnetic resonance imaging training

239

Cardiac magnetic resonance imaging using radial k-space sampling and self-calibrated partial parallel reconstruction

240

Cardiac magnetic resonance imaging: A teaching atlas with emphasizing current clinical indications

241

Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease

242

Cardiac magnetic resonance in outpatients in Germany—indications, complications and protocol suggestions from a high-volume center

243

Cardiac Magnetic Resonance Measurements of Area at Risk and Infarct Size in Ischemic Syndromes

244

Cardiac Magnetic Resonance Predicts Outcome in Patients With Premature Ventricular Complexes of Left Bundle Branch Block Morphology

245

Cardiac magnetic resonance training: How we can get there from here

246

Cardiac Magnetic Resonance With Edema Imaging Identifies Myocardium at Risk and Predicts Worse Outcome in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

247

Cardiac Magnetic Resonance-Directed Intervention in Non–ST-Segment Elevation Acute Coronary Syndrome

248

Cardiac Malformations in Fetuses of Gestational and Pre Gestational Diabetic Mothers

249

Cardiac malignant lymphoma with atrial arrhythmias

250

Cardiac management by pediatricians versus pediatric cardiologists in an inpatient academic center

251

Cardiac Manifestation of Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)

252

Cardiac manifestations in antiphospholipid syndrome

253

Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population

254

Cardiac Manifestations in Iranian Patients with Behçet’s Disease

255

Cardiac manifestations of Anderson–Fabry disease in heterozygous females

256

Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection

257

Cardiac marker testing: Where should we focus?

258

Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction

259

Cardiac Markers in the Early Diagnosis and Management of Patients with Acute Coronary Syndrome

260

Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing?

261

Cardiac Markers of Pre-Clinical Disease in Adolescents With the Metabolic Syndrome: The Strong Heart Study

262

Cardiac Markers: Centralized or Decentralized Testing?

263

Cardiac mass of the right atrium: an incidental finding

264

Cardiac mass-to-maximum power output: A novel index to assess left ventricular efficiency during exercise stress echocardiography

265

Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog

266

Cardiac Mast Cells: Implications for Heart Failure

267

Cardiac material markers from tagged MR images

268

Cardiac matrix metalloproteinase activation in patients undergoing coronary artery bypass grafting

269

Cardiac Medical Therapy Following Coronary Artery Bypass Graft Surgery

270

Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials Review Article

271

Cardiac Medical Therapy Post-Coronary Bypass Grafting

272

273

Cardiac Memory versus Likelihood of Ischemic Heart Disease in Hypertensive Patients with Ventricular Repolarization Abnormalities after Repetitive Uniform Ventricular Extrasystoles

274

Cardiac metabolism and function in type 2 diabetic (db/db) mice — Effect of PPARα agonist treatment

275

Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis

276

Cardiac Metal Contents After Infusions of Manganese An Experimental Evaluation in the Isolated Rat Heart

277

Cardiac Metastases of Malignant Melanoma

278

Cardiac metastasis after squamous cell carcinoma of the oral cavity: Case report

279

Cardiac Metastasis from a Renal Cell Carcinoma without Contiguous Vena Caval Involvement

280

Cardiac metastasis from a urothelial cell carcinoma: a commented case report

281

Cardiac metastasis mimicking acute STelevation myocardial infarction

282

Cardiac metastasis of tongue cancer may cause sudden death

283

Cardiac Metastatic Melanoma Investigated by Magnetic Resonance Imaging

284

Cardiac microvascular changes in DOCA-salt hypertensive rats: effect of endothelin ETA receptor antagonism

285

Cardiac Misconceptions and Patients Point of View about Explanation of Medical Diagnosis and the Therapeutic Regimen

286

Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related

287

Cardiac modulation of startle: Effects on eye blink and higher cognitive processing

288

Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device

289

Cardiac monitoring after phenytoin overdose

290

Cardiac Monitoring Of Children With Household Electrical Injuries, ,

291

Cardiac morphogenetic defects and conduction abnormalities in mice homozygously deficient for connexin40 and heterozygously deficient for connexin45

292

Cardiac Morphology and Function in Senescent Rats: Gender-Related Differences

293

Cardiac Morphology and Left Ventricular Function in Normotensive Morbidly Obese Patients With and Without Congestive Heart Failure, and Effect of Weight Loss

294

Cardiac motion recovery using an incompressible B-solid model

295

Cardiac MRI in a Patient with Amyloidosis

296

Cardiac MRI in a Patient with Coincident Left Ventricular Non-Compaction and Hypertrophic Cardiomyopathy

297

Cardiac MRI in a Patient with Coincident Left Ventricular Non-Compaction and Hypertrophic Cardiomyopathy

298

Cardiac MRI in a Patient with Myocarditis

299

Cardiac MRI of ischemic heart disease at 3 T: potential and challenges

300

Cardiac multidetector-row computed tomography in patients with unstable angina

301

Cardiac muscle tissue engineering

302

Cardiac myocyte cytokinesis: The contractile ring is the thing

303

Cardiac myocyte nuclear size and ploidy status decrease after mechanical support

304

Cardiac myocyte proliferation requires activation of protein kinase C-epsilon

305

Cardiac myocytes derived from Nkx2.5-GFP knock-in murine embryonic stem cell: Electrophysiological differentiation and coupling with native cardiac myocytes

306

Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA

307

Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR

308

Cardiac Myofilament Protein Function is Altered During Sepsis

309

Cardiac myofilaments: mechanics and regulation

310

Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay

311

Cardiac myosin heavy chain isoenzymes and self ventricular defibrillation

312

Cardiac myosin phosphatase

313

Cardiac Myosin-Binding Protein C (MyBP-C): Identification of Protein Kinase A and Protein Kinase C Phosphorylation Sites

314

Cardiac Myxoma Removal and Coronary Artery Bypass Grafting in a MiddleAged Woman: A Case Report

315

Cardiac Myxoma with Glandular Component

316

Cardiac Myxoma, a Rare but Most Common Encountered Cardiac Tumor: A Single Center Experience

317

Cardiac Myxoma: 40 Years’ Experience in 63 Patients

318

Cardiac myxoma: a cytogenetic study of two cases

319

Cardiac myxoma: clinical experiences with twenty-five patients in Korea

320

Cardiac myxomas: Clinical and echocardiographic profile

321

Cardiac myxosarcoma: A case report

322

Cardiac NA,K-ATPase during hypertension: Regulatory role of nitric oxide

323

Cardiac Na/Ca Exchange Function in Rabbit, Mouse and Man: Whatʹs the Difference?

324

Cardiac Na+–H+Exchanger During Postnatal Development in the Rat: Changes in mRNA Expression and Sarcolemmal Activity

325

Cardiac Natriuretic Peptides: Gaining Further Insights Into Structure–Function Relationships

326

Cardiac NGF and GDNF expression during Trypanosoma cruzi infection in rats

327

Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy

328

Cardiac nitric oxide synthases are elevated in dietary copper deficiency

329

Cardiac nociceptors innervated by vagal afferents in rats

330

Cardiac Noradrenaline Release Accelerates Adenosine Formation in the Ischemic Rat Heart: Role of Neuronal Noradrenaline Carrier and Adrenergic Receptors

331

Cardiac nuclear medicine studies

332

Cardiac observations late after operative transmyocardial laser “revascularization”

333

Cardiac operation for a patient with autoimmune hemolytic anemia with warm-reactive antibodies

334

Cardiac operations during pregnancy: review of factors influencing fetal outcome

335

Cardiac Operations in Children With Marfan’s Syndrome: Indications and Results

336

Cardiac operations in octogenarians: perioperative risk factors for death and impaired autonomy

337

Cardiac Operations in Patients 80 Years Old and Older

338

Cardiac Operations in Patients 90 Years of Age and Older

339

Cardiac operations in patients aged 70 years and over: Mortality, length of stay, and hospital charge

340

Cardiac Operations in Patients With Cirrhosis

341

Cardiac Operations in Solid-Organ Transplant Recipients

342

Cardiac operations in the elderly: who is at risk?

343

Cardiac Origins of the Postural Orthostatic Tachycardia Syndrome

344

Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities: Zaroff JG, Rordorf GA, Newell JB, et al Neurosurgery 44:34–40 January 1999

345

Cardiac Outcomes in Coronary Patients With Submaximum Dobutamine Stress Echocardiography

346

Cardiac Outcomes in Young Adult Survivors of the Arterial Switch Operation for Transposition of the Great Arteries

347

Cardiac Outcomes With Submaximal Normal Stress Echocardiography: A Meta-Analysis

348

Cardiac Output Augmentation During Hypoxemia Improves Cerebral Metabolism After Hypothermic Cardiopulmonary Bypass

349

Cardiac output in single-lead VDD pacing versus rate-matched VVIR pacing

350

Cardiac output response to dynamic exercise after atrial switch repair for transposition of the great arteries

351

Cardiac Output Responses During Exercise in Volume-Expanded Heart Transplant Recipients

352

Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: Role of insulin signaling and ER stress

353

Cardiac overexpression of the α1A-adrenergic receptor limits post-infarct ventricular remodeling and dysfunction, and improves survival

354

Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase

355

Cardiac oxygenation by extracorporeal membrane oxygenation in exteriorized fetal lambs, , ,

356

Cardiac pacemaker cell failure with preserved If, ICaL, and IKr: A lesson about pacemaker function learned from ischemia-induced bradycardia

357

Cardiac pacemaker dysfunction in children after thoracic drainage catheter manipulation

358

Cardiac Pacemaker Infection: Surgical Management With and Without Extracorporeal Circulation

359

Cardiac pacemaker lead extraction using conventional techniques:a single centre experience

360

Cardiac pacemaker: In vitro assessment at 1.5 T

361

Cardiac pacemakers: Evaluation and management of malfunctions

362

Cardiac pacemaking: If vs. Ca2+, is it really that simple?

363

364

365

Cardiac Pacing and Psychologic Disorders

366

Cardiac pacing in balloon aortic valvuloplasty

367

Cardiac pacing in premature infants and neonates: steroid eluting leads and automatic output adaptation

368

Cardiac pacing: atrial fibrillation may go unrecognised

369

Cardiac pacing: the state of the art

370

Cardiac papillary fibroelastoma

371

Cardiac Papillary Fibroelastoma

372

Cardiac papillary fibroelastoma

373

Cardiac papillary fibroelastoma as a reason of transient ischemic attack for a young patient

374

Cardiac papillary fibroelastoma in left ventricular apex

375

Cardiac papillary fibroelastoma manifested as a left ventricular cystic mass

376

Cardiac papillary fibroelastoma on the pulmonary valve: a rare cardiac tumor

377

Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases

378

Cardiac papillary fibroelastomas: Rationale for excision

379

Cardiac Paraganglioma Presenting With Acute Myocardial Infarction and Stroke

380

Cardiac Paraganglioma, Recent Advances in Clinicopathologic Features

381

Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes

382

Cardiac Parasympathetic Reactivation in Elite Soccer Players During Different Types of Traditional High-Intensity Training Exercise Modes and Specific Tests: Interests and Limits

383

Cardiac Parasympathetic Reactivation in Elite Soccer Players During Different Types of Traditional High-Intensity Training Exercise Modes and Specific Tests: Interests and Limits

384

Cardiac pathologic findings reveal a high rate of sudden cardiac death of undetermined etiology in younger women

385

Cardiac pathological changes of Atlantic salmon (Salmo salar L.) affected with heart and skeletal muscle inflammation (HSMI)

386

Cardiac patients’ beliefs about their illness and treatment: A sequential exploratory mixed methods design

387

Cardiac patients’ perception about psychological risk factors on chest pain intensity and discomfort

388

Cardiac pentastomiasis and tuberculosis: The worm-eaten heart

389

Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice

390

Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder Original Research Article

391

Cardiac performance early after cardioversion from atrial fibrillation, , , , ,

392

CARDIAC PERFORMANCE IN END STAGE RENAL DISEASE DIABETIC PATIENTS WITH ARTERIOVENOUS FISTULA

393

Cardiac performance is reduced following high-fat diet

394

Cardiac Performance Measure Compliance in Outpatients: The American College of Cardiology and National Cardiovascular Data Registryʹs PINNACLE (Practice Innovation And Clinical Excellence) Program

395

Cardiac phenotypes in relaxin knockout mice: Importance of the gender

396

Cardiac pheochromocytoma

397

Cardiac pheochromocytoma: resection after diagnosis by 111-indium octreotide scan

398

Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis

399

Cardiac Physical Diagnosis in the Digital Age: An Important but Increasingly Neglected Skill (from Stethoscopes to Microchips)

400

Cardiac plasmacytoma

401

Cardiac Positron Emission Tomography

402

Cardiac positron emission tomography and the role of adenosine pharmacologic stress

403

Cardiac Positron Emission Tomography as a Prognostic Indicator of Cardiac Sarcoidosis

404

Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

405

Cardiac positron emission tomography imaging with [11c]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure

406

Cardiac Positron Emission Tomography/Computed Tomography Imaging of the Renin-Angiotensin System in Humans Holds Promise for Image-Guided Approach to Heart Failure Therapy

407

Cardiac potassium channel dysfunction in sudden infant death syndrome

408

Cardiac potassium currents and channels: Part II: Implications for clinical practice and therapy

409

Cardiac potassium currents and channels-Part I: Basic science aspects

410

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry Original Research Article

411

Cardiac Power Output during Dobutamine Stress Test in Horses

412

Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease

413

Cardiac problems related to burns and/or burn treatment

414

Cardiac procedure use following acute myocardial infarction among American Indians

415

Cardiac Procedures in Lung Transplant Recipients Do Not Increase Mortality in Selected Patients

416

Cardiac Procedures in Patients With a Body Mass Index Exceeding 45: Outcomes and Long-Term Results

417

Cardiac progenitor cells application in cardiovascular disease

418

Cardiac protection during acute myocardial infarction: Where do we stand in 2004? Review Article

419

Cardiac protection: Evolving role of angiotensin receptor blockers

420

Cardiac Pseudopyogenic Granuloma: A Type of Vascular Hyperplasia in the Transplanted Heart Mimicking Pyogenic Granuloma

421

Cardiac pulsations in patients with isolated right ventricular infarction

422

Cardiac Regeneration Review Article

423

Cardiac Rehab: Bridging the Transition from Hospital to Home

424

Cardiac rehabilitation

425

Cardiac rehabilitation after myocardial infarction in the community Original Research Article

426

Cardiac rehabilitation and depression

427

Cardiac Rehabilitation and Prevention of Cardiovascular Disease: A Role for Autonomic Cardiovascular Regulation

428

Cardiac rehabilitation and secondary prevention in Australia and New Zealand

429

Cardiac Rehabilitation and Secondary Prevention Program effect in Chronic Total Occlusion Percutaneous Coronary Intervention patients

430

Cardiac Rehabilitation and Survival in Older Coronary Patients

431

Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction

432

Cardiac Rehabilitation Following Myocardial Infarction

433

Cardiac Rehabilitation for Patients With Ventricular Assist Devices: An Offer to Improve Strong Collaborative Relationships

434

Cardiac rehabilitation I: review of psychosocial factors

435

Cardiac rehabilitation II: referral and participation

436

Cardiac Rehabilitation Improves the QRS Fragmentation in Patients With ST Elevatıon Myocardial Infarction

437

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

438

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

439

Cardiac rehabilitation in skilled nursing facilities: A missed opportunity

440

Cardiac rehabilitation in the elderly

441

Cardiac Rehabilitation Program with High Intensity Aerobic Exercise Can Reverse Diastolic Impairment in Patients Undergoing Coronary Artery Bypass Surgery

442

Cardiac rehabilitation services in England and Wales: a national survey

443

Cardiac rehabilitation using simultaneous voice and electrocardiographic transtelephonic monitoring

444

Cardiac Rehabilitation, Exercise Training, and Anxiety

445

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors

446

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors: Reply

447

Cardiac rehabilitation: A review of current developments

448

Cardiac rehabilitation: How can it be improved?

449

Cardiac Relapse of Acute Myeloid Leukemia afterAllogeneic Hematopoietic Stem Cell Transplantation

450

Cardiac Release and Kinetics of Endothelin After Severe Short-Lasting Myocardial Ischemi

451

Cardiac Release and Kinetics of Endothelin After Uncomplicated Percutaneous Transluminal Coronary Angioplasty

452

Cardiac remodeling after long term norepinephrine treatment in rats

453

Cardiac remodeling after long-term stimulation by antibodies against the α1-adrenergic receptor in rats

454

Cardiac remodeling and failure: From molecules to man (Part I)

455

Cardiac remodeling and failure: From molecules to man (Part II)

456

Cardiac remodeling and failure: From molecules to man (Part III)

457

Cardiac remodeling and the role of matrix metalloproteinases in chronic anthracycline cardiotoxicity

458

Cardiac remodeling in coronary artery disease

459

Cardiac remodeling precedes clinical hypertension in offspring of hypertensive parents. The Bergen Blood Pressure Study

460

Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats

461

Cardiac remodeling: is 8 the heart’s lucky number?

462

Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling

463

Cardiac remodelling in the era of aggressive medical therapy: does it still exist?

464

Cardiac reoperation by Carpentier bicaval femoral venous cannula: GATA experience

465

Cardiac reoperation in the intensive care unit

466

Cardiac reoperations in octogenarians: analysis of outcomes

467

Cardiac Repair in Patients with Trisomy 18: Total or Palliative?

468

Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction

469

Cardiac repolarisation can be detected as an ordered spatial process on the body surface

470

Cardiac Repolarization Changes in the Children with Breath-Holding Spells

471

Cardiac repolarization is prolonged in CD4C/HIV transgenic mice

472

Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management

473

Cardiac rescue with intra-aortic balloon counterpulsation in refractory shock due to acute meningococcemia

474

Cardiac response to prolonged strenuous exercise: A physiologic model for stunning myocardium

475

Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation

476

Cardiac responses to long duration and high magnitude +Gz exposure in pilots: An observational study

477

Cardiac Rest and Reserve Function in Patients With Fontan Circulation Original Research Article

478

Cardiac Restriction Secondary to Massive Calcific Deposits in the Left Ventricular Cavity

479

Cardiac Resurrection After Bone-Marrow-Derived Mononuclear Cell Transplantation During Left Ventricular Assist Device Support

480

Cardiac resynchronisation – a new standard in heart failure therapy

481

Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC

482

Cardiac Resynchronisation Therapy in Heart Failure

483

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure

484

Cardiac resynchronization by pacing: an electrical treatment of heart failure

485

Cardiac Resynchronization Devices: The Food and Drug Administration’s Regulatory Considerations Review Article

486

Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?

487

Cardiac Resynchronization in Mildly Symptomatic Heart Failure and Asymptomatic Patients

488

Cardiac Resynchronization in Patients With Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies Original Research Article

489

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing

490

Cardiac Resynchronization Therapy

491

Cardiac resynchronization therapy 101: If itʹs not late, pacing it early wonʹt help

492

Cardiac Resynchronization Therapy and Atrial Tachyarrhythmias: A Question Still Searching for an Answer

493

Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block

494

Cardiac resynchronization therapy for an unusual cause of cardiomyopathy

495

Cardiac Resynchronization Therapy for Mitral Systolic Anterior Motion in a Child

496

Cardiac Resynchronization Therapy for the Failing Fontan Patient

497

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

498

Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure Original Research Article

499

Cardiac Resynchronization Therapy Improves Heart Rate Profile and Heart Rate Variability of Patients With Moderate to Severe Heart Failure Original Research Article

500

Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology: Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study

501

Cardiac resynchronization therapy in chronic heart failure: How to select the patient that will benefit?

502

Cardiac resynchronization therapy in congenital heart disease

503

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex Original Research Article

504

Cardiac Resynchronization Therapy in Patients With End-Stage Inotrope-Dependent Class IV Heart Failure

505

Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block Versus Right Ventricular Pacing

506

Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure: A Systematic Review and Meta-Analysis

507

Cardiac resynchronization therapy in patients with narrow QRS

508

Cardiac Resynchronization Therapy in Patients With Systolic Left Ventricular Dysfunction and Symptoms of Mild Heart Failure Secondary to Ischemic or Nonischemic Cardiomyopathy

509

Cardiac Resynchronization Therapy Is More Effective in Women Than in Men: The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Trial

510

Cardiac Resynchronization Therapy May Avoid Dilated Rather Than Ischemic Cardiomyopathy Patients the Need for Primary Prevention Defibrillator Implantation

511

Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients

512

Cardiac Resynchronization Therapy Optimization Using Trans Esophageal Doppler in Patients with Dilated Cardiomyopathy

513

Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

514

Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay

515

Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony

516

Cardiac resynchronization therapy upregulates cardiac autonomic control

517

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients

518

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients: Reply

519

Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure Original Research Article

520

Cardiac resynchronization therapy: A regulatory perspective

521

Cardiac Resynchronization Therapy: Antiarrhythmic or Proarrhythmic?

522

Cardiac Resynchronization Therapy: Are Modern Myths Preventing Appropriate Use?

523

Cardiac resynchronization therapy: caveat medicus! Review Article

524

Cardiac Resynchronization Therapy: Location Matters

525

Cardiac Resynchronization Therapy: Part 1—Issues Before Device Implantation Review Article

526

Cardiac Resynchronization Therapy: Part 2—Issues During and After Device Implantation and Unresolved Questions Review Article

527

Cardiac Resynchronization Therapy: The More Pacing Sites, the Better the Outcome?

528

Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block

529

Cardiac Resynchronization With Sequential Biventricular Pacing for the Treatment of Moderate-to-Severe Heart Failure Original Research Article

530

Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure

531

Cardiac retransplantation in children

532

Cardiac rhabdomyoma

533

Cardiac rhabdomyoma in an adult patient presenting with right ventricular outflow tract obstruction

534

Cardiac Rhabdomyoma In Familial Tuberous Sclerosis

535

Cardiac Rhabdomyomas and Congenital Hypothyroidism: A Coincidence or Hamartia

536

Cardiac Rhabdomyomas and Obstructive Left Heart Disease: Histologically but Not Functionally Benign

537

Cardiac rhythm and symptomatic arrhythmia in right atrial isomerism

538

Cardiac rhythm disturbances in a bactrian camel (Camelus bactrianus) during anaesthesia for oral surgery: a case report

539

Cardiac Rhythm Management Devices: When Regulatory Agencies “Over-Regulate”

540

Cardiac risk factors

541

Cardiac risk factors

542

Cardiac risk for vascular surgery

543

Cardiac Risk in Patients Aged >75 Years With Asymptomatic, Severe Aortic Stenosis Undergoing Noncardiac Surgery

544

Cardiac risk in pregnant women with rheumatic mitral stenosis

545

Cardiac risk management in severe mental illness

546

Cardiac risk of noncardiac surgery in patients with hypertrophic cardiomyopathy

547

Cardiac risk stratification

548

Cardiac Risk Stratification in Renal Transplantation Using a Form of Artificial Intelligence

549

Cardiac risk: Theme con variations

550

Cardiac rupture – experience-based cardiology

551

Cardiac Rupture After Catheter Ablation Procedure

552

Cardiac rupture and tamponade during ventriculography

553

Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the late assessment of thrombolytic efficacy (LATE) study

554

Cardiac rupture complicating myocardial infarction

555

Cardiac rupture during contrast-enhanced dobutamine stress echocardiography

556

Cardiac rupture during exercise test in post-myocardial infarction patients: a case report and brief review of the literature

557

Cardiac Rupture During Vacuum-Assisted Closure Therapy

558

Cardiac rupture or pericardial effusion?

559

Cardiac Sarcoidosis

560

Cardiac Sarcoidosis

561

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias

562

Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography

563

Cardiac sarcoidosis presenting as Heerfordt’s syndrome

564

Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis

565

Cardiac Sarcoplasmic Reticular Function in Rats with Chronic Heart Failure Following Myocardial Infarction

566

Cardiac Sca-1+ and side population cells in cardiac regeneration

567

Cardiac screening proposed for HIV-1-infected children

568

Cardiac sensitization: methodology and interpretation in risk assessment

569

Cardiac signal extraction in patients with Implantable Cardioverter Defibrillators

570

Cardiac Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Finally Up to Speed?

571

Cardiac sources of embolic cerebral infarction in transesophageal echocardiography

572

CARDIAC SOURCES OF EMBOLISM IN IRANIAN STROKE PATIENTS

573

Cardiac specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy from aortic constriction

574

Cardiac specific two-year mortality related to initial post-thrombolytic flow grade

575

Cardiac stabilizer for minimally invasive direct coronary artery bypass

576

Cardiac state diagnosis using adaptive neuro-fuzzy technique

577

Cardiac Steatosis and Left Ventricular Hypertrophy in Patients With Generalized Lipodystrophy as Determined by Magnetic Resonance Spectroscopy and Imaging

578

Cardiac Steatosis and Myocardial Dysfunction

579

Cardiac Stem Cell Transplantation

580

Cardiac stem cells and myocardial disease

581

Cardiac stem cells: paradigm shift or broken promise? A view from developmental biology Original Research Article

582

Cardiac stents: the next generation

583

Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker

584

Cardiac Strain between Normal Weight and Overweight Workers in Hot/Humid Weather in the Persian Gulf

585

Cardiac stress adaptation and hyperlipidemia: Role of matrix metalloproteinase-2

586

Cardiac Structural and Electrical Adaptation in Male Active Athletes. QT Interval Could it be the Clue to Sudden Cardiac Death?

587

Cardiac Structure and Exercise Blood Pressure in Urban and Rural Canadian Men of Icelandic Descent

588

Cardiac structure and function Review Article

589

Cardiac structure and function after short-term ethanol consumption in rats

590

Cardiac Structure and Function as Predictors of Mortality in Persons 85 Years of Age

591

Cardiac structure and function in fetuses of mothers infected with HIV: The prospective P2C2HIV multicenter study

592

Cardiac Structure and Function in Persons 85 Years of Age

593

Cardiac Structure and Function in Young and Senescent Mice Heterozygous for a Connexin43 Null Mutation

594

Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity

595

Cardiac Surgeon Report Cards, Referral for Cardiac Surgery, and the Ethical Responsibilities of Cardiologists

596

Cardiac surgeons in England face publication of outcomes data

597

Cardiac surgery

598

Cardiac surgery and cold-reactive proteins

599

Cardiac surgery and the acute care nurse practitioner—“the perfect link”

600

Cardiac Surgery for Grown-Up Congenital Heart Patients: Survey of 307 Consecutive Operations from 1991 to 1994

601

Cardiac surgery for octogenarians: is it an informed decision?

602

Cardiac surgery in a fixed-reimbursement environment

603

Cardiac surgery in African Americans

604

Cardiac Surgery in Children With End-Stage Liver Disease Awaiting Liver Transplantation

605

Cardiac surgery in moderate to end-stage renal failure: analysis of risk factors

606

Cardiac surgery in nonagenarians: Pushing the boundary one further decade

607

Cardiac surgery in octogenarians with poor lung function

608

Cardiac surgery in octogenarians: can elderly patients benefit? quality of life after cardiac surgery

609

Cardiac surgery in octogenarians: have we gone too far or not far enough?

610

Cardiac surgery in octogenarians: The informed decision is not whether to have it, but rather when and where to have it

611

Cardiac surgery in patients infected with the human immunodeficiency virus

612

Cardiac Surgery in Patients on Dialysis: Decreased 30-Day Mortality, Unchanged Overall Survival

613

Cardiac Surgery in Patients With Body Mass Index of 50 or Greater

614

Cardiac surgery in patients with end-stage renal disease: 10-year experience

615

Cardiac Surgery in Patients With Liver Cirrhosis

616

Cardiac Surgery in Renal Transplant Recipients: Experience from Washington Hospital Center

617

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

618

Cardiac Surgery in the Adult, second edition: Edited by Lawrence H. Cohn, MD, and L. Henry Edmunds, MD, New York, McGraw-Hill Professional, 2003, 1573 pp, illustrated, $250.00, ISBN: 0-07139-1290

619

Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome

620

Cardiac surgery report cards: comprehensive review and statistical critique

621

Cardiac surgery report cards: making the grade

622

Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement

623

Cardiac Surgery Risk Models: A Position Article

624

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia

625

Cardiac Surgery with Crystalloid Cardioplegia: Improved Functional Recovery Due to Molecular Adaptations in Adult Rat Hearts

626

Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia–reperfusion

627

Cardiac surgical conditions induced by β-blockade: Effect on myocardial fluid balance

628

Cardiac surgical implications of calcium dyshomeostasis in the heart

629

Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy

630

Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

631

Cardiac sympathetic denervation detected with dobutamine infusion in patients with Parkinsonʹs disease: Correlation with cardiac 123I-metaiodobenzylguanidine (MIBG) uptake – A follow-up report

632

Cardiac Sympathetic Denervation in Patients With Coronary Artery Disease Without Previous Myocardial Infarction

633

Cardiac sympathetic denervationmodulates the sympathoexcitatoryresponse to acute myocardial ischemia

634

Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients Original Research Article

635

Cardiac sympathetic innervation and control of potassium channel function

636

Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardi

637

Cardiac Syndrome X and Endothelial Dysfunction: New Concepts in Prognosis and Treatment

638

Cardiac syndrome X versus metabolic syndrome X

639

Cardiac syndrome X: Clinical characteristics and left ventricular function: Long-term follow-up study

640

Cardiac T2* measurements in patients with iron overload: a comparison of imaging parameters and analysis techniques

641

Cardiac Tamponade After a Systemic–Pulmonary Shunt Complicated by Serous Leakage

642

Cardiac tamponade after removal of atrial intracardiac monitoring catheters in a pediatric patient: Case report

643

Cardiac tamponade as a complication of catheterization of the subclavian vein—prevention and principles of management

644

Cardiac tamponade as a life-threatening complication in antireflux surgery

645

Cardiac Tamponade as an Initial Manifestation of Cervical Cancer

646

Cardiac tamponade as initial presentation of Sheehanʹs Syndrome

647

Cardiac tamponade as manifestation of advanced thymic carcinoma

648

Cardiac Tamponade as the Initial Presentation of Acute MyeloidLeukemia: A Case Report with Review of the Literature

649

Cardiac tamponade as unusual presentation of underlying unrecognized cancer

650

Cardiac Tamponade by Hydatid Pericardial Cyst: A Rare Case Report

651

Cardiac tamponade caused by a leaking coronary saphenous vein graft aneurysm

652

Cardiac Tamponade Caused by Cutibacterium acnes: An Updated and Comprehensive Review of the Literature

653

Cardiac tamponade complicating trimodal therapy for malignant mesothelioma

654

Cardiac tamponade due to pneumopericardium

655

Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm

656

Cardiac tamponade during thoracic endovascular aortic repair

657

Cardiac tamponade following pacemaker implantation

658

Cardiac tamponade from central venous catheters

659

Cardiac Tamponade from Purulent Pericarditis due to Cutibacterium acnes

660

Cardiac tamponade in a neglected case of thyroid agenesis

661

Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma

662

Cardiac tamponade in acquired immunodeficiency syndrome

663

Cardiac tamponade in acute rheumatic fever

664

Cardiac tamponade in Hashimotoʹs disease

665

Cardiac tamponade in hereditary hemorrhagic telangiectasia

666

Cardiac Tamponade in Patients with COVID-19 Infection; A Case Report

667

Cardiac tamponade in the “new device” era: Evaluation of 6999 consecutive percutaneous coronary interventions

668

Cardiac tamponade in the fibrinolytic era: Analysis of >100 000 patients with ST-segment elevation myocardial infarction

669

CARDIAC TAMPONADE SECONDARY TO CARDIOPULMONARY RESUSCITATION IN APATIENT RECEIVING ANTIPLATELET THERAPY

670

Cardiac tamponade without pericardial effusion after blunt chest trauma

671

Cardiac Tamponade: A Rare Presentation of Childhood Hypothyroidism

672

Cardiac Tamponade; A rare Presentation of Childhood Hypothyroidism

673

Cardiac teratogenicity of trichloroethylene metabolites

674

Cardiac thromboemboli complicating a stab wound to the heart

675

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures

676

Cardiac toxicity in breast cancer patients: From a fractional point of view to a global assessment

677

Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer

678

Cardiac toxicity of sunitinib

679

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma: Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H, Clinical Division of Oncology, Department of Medicine I and

680

Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease

681

Cardiac Transplant Following Failed Fontan or Glenn Procedures

682

Cardiac transplant rejection is associated with a decrease in the high-frequency components of the high-resolution, signal-averaged electrocardiogram

683

Cardiac transplantation after mechanical circulatory support: A Canadian perspective

684

Cardiac transplantation after the Fontan or Glenn procedure Original Research Article

685

Cardiac transplantation and simultaneous surgical repair of an aortic aneurysm

686

Cardiac Transplantation for Cardiac Sarcoidosis With Initial Diagnosis by Examination of the Left Ventricular Apical “Core” Excised for Insertion of a Left Ventricular Assist Device for Severe Chronic Heart Failure

687

Cardiac transplantation for hypertrophic cardiomyopathy associated with sengersʹ syndrome

688

Cardiac transplantation for the cardiologist not trained in transplantation

689

Cardiac Transplantation for The Iranian Journal of Cardiac Surgery Doxorubicin-induced Heart Failure after Chemotherapy of Ewing’s Sarcoma

690

Cardiac transplantation in a patient with protein S deficiency

691

Cardiac Transplantation in Adults With Aortic Valve Disease With Focus on the Bicuspid Aortic Valve

692

Cardiac Transplantation in Adults With Small Hearts

693

Cardiac Transplantation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

694

Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

695

Cardiac Transplantation in Pediatric Patients: Fifteen-Year Experience of a Single Center

696

Cardiac Transplantation: The Columbia University Medical Center/New York—Presbyterian Hospital Manual

697

Cardiac Troponin After Major Vascular Surgery: The Role of Perioperative Ischemia, Preoperative Thallium Scanning, and Coronary Revascularization Original Research Article

698

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

699

Cardiac Troponin and Brain Natriuretic Peptide: Prediction of Mortality Among Septic Pts

700

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan

701

Cardiac Troponin Elevation After Long-Distance Cycling is Associated with Oxidative Stress and Exercise Intensity: An Observational Study

702

Cardiac Troponin Elevations in Chronic Renal Failure: Prevalence and Clinical Significance

703

Cardiac troponin I

704

Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations

705

Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency

706

Cardiac Troponin I and Tension Generation of Skinned Fibres in the Developing Rat Heart

707

Cardiac troponin I and the occurrence of cardiac arrhythmias in horses with experimentally induced endotoxaemia

708

Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers

709

Cardiac troponin I as predictor of major cardiac events in emergency department patients with acute chest pain

710

Cardiac troponin I as a marker for AMI

711

Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs

712

Cardiac Troponin I as a Marker of Sepsis Severity and Mortality Prediction

713

Cardiac troponin i as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: a pilot study

714

Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction

715

Cardiac Troponin I Elevation in Hospitalized Patients Without Acute Coronary Syndromes

716

Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients

717

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

718

Cardiac troponin I in acute coronary ischemic syndromes. Epidemiological and clinical correlates

719

Cardiac troponin i in acute pericarditis

720

Cardiac troponin I in aortic valve disease

721

Cardiac troponin I in neonates undergoing the arterial switch operation

722

Cardiac Troponin I in Patients With Acute Lower Limb Ischemia

723

Cardiac Troponin I Levels Are Normal or Minimally Elevated After Transthoracic Cardioversion

724

Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population

725

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences

726

Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock

727

Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage

728

Cardiac troponin I proves less accurate in low-risk cardiac patients

729

Cardiac Troponin I Release After Coronary Artery Bypass Grafting Operation: Effects on Operative and Midterm Survival

730

Cardiac troponin I release after open heart surgery: a marker of myocardial protection?

731

Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms

732

Cardiac troponin I release in heart transplantation

733

Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditis

734

Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis

735

Cardiac troponin I: A potential marker of exercise intolerance in patients with moderate heart failure

736

Cardiac Troponin Increases Among Runners in the Boston Marathon

737

Cardiac Troponin Levels Following Complicated and Uncomplicated Epileptic Seizures

738

Cardiac troponin release in response to transient ST segment depression

739

Cardiac Troponin T (cTnT) in Hemodialysis Patients with Asymptomatic and Symptomatic Atherosclerosis

740

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

741

Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon

742

Cardiac troponin T and myocardial injury during routine cardiac catheterisation in children

743

Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain, ,

744

Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function Original Research Article

745

Cardiac troponin T concentration after coronary balloon angioplasty

746

Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality

747

Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes

748

Cardiac Troponin T in Patients With Clinically Suspected Myocarditis

749

Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema

750

Cardiac Troponin T Levels for Risk Stratification in Pediatric Open Heart Surgery

751

Cardiac troponin T levels in umbilical cord blood,

752

Cardiac Troponin T Levels of Umbilical Cord in Neonates with Abnormal Fetal Heart Rate

753

Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T–tropomyosin interaction and causes a Ca2+ desensitization

754

Cardiac Troponin T Release Is Stimulated by Endurance Exercise in Healthy Humans

755

Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting, ,

756

Cardiac Troponin: A Villain or a Decent Actor in the Process of Ongoing Myocardial Injury?

757

Cardiac troponin-I content of skeletal muscle in patients with renal failure

758

Cardiac troponins after a downhill marathon

759

Cardiac troponins and oxidative stress markers in non-pregnant, pregnant and preeclampsia women

760

Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome

761

Cardiac troponins in congestive heart failure, ,

762

Cardiac Troponins in Patients With Chronic Kidney Disease and Kidney Transplant Recipients Without Acute Cardiac Symptoms

763

Cardiac troponins in renal insufficiency: Review and clinical implications

764

Cardiac Troponins in Young Marathon Runners

765

Cardiac Troponins: A Tool for a Personalized Medicine Strategy in Stable Coronary Artery Disease?

766

Cardiac troponins: IT upgrade for the heart

767

Cardiac tuberculoma presenting as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

768

Cardiac tuberculosis presenting as small intestinal gangrene

769

Cardiac tumor comprising two components including typical myxoma and atypical hypercellularity suggesting a malignant change

770

Cardiac tumor due to Erdheim-Chester disease

771

Cardiac Tumor-Like Mass in a Patient With Systemic Vasculitis

772

Cardiac Tumors and Associated Arrhythmias in Pediatric Patients, With Observations on Surgical Therapy for Ventricular Tachycardia

773

Cardiac Unloading Alters Contractility and Calcium Homeostasis in Ventricular Myocytes

774

Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection Original Research Article

775

Cardiac Uses of Phosphodiesterase-5 Inhibitors

776

Cardiac vagal activity: a target for intervention in heart disease

777

Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease

778

Cardiac vagal control in the severity and course of depression: The importance of symptomatic heterogeneity

779

Cardiac vagal responsiveness during development in spontaneously hypertensive rats

780

Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine

781

Cardiac Valve Granulocytic Sarcoma Infiltration as an Complicating Acute Myelogenous Leukemia: a Case Report

782

Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury

783

Cardiac Valve Interstitial Cells: Regulator of Valve Structure and Function

784

Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies

785

Cardiac Valve Prostheses at Autopsy: An Analysis of 337 Cases with Clinicopathologic Correlation

786

Cardiac valve replacement in human immunodeficiency virus–infected patients

787

Cardiac valve replacement in patients on dialysis

788

Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival

789

Cardiac valves and valvular pathology: Update on function, disease, repair, and replacement

790

Cardiac Valvular Calcification in Hemodialysis Patients

791

Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patients

792

Cardiac Variables as Main Predictors of Endotracheal Reintubation Rate after Cardiac Surgery

793

Cardiac Varix in Relation to Right Atrial Free Wall Presenting as a Mass Compressing the Right Atrium and Mimicking a Pericardial Cyst

794

Cardiac Ventricular Diastolic and Systolic Duration in Children With Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

795

Cardiac versus noncardiac limits to exercise after heart transplantation, , ,

796

Cardiac Wegener’s granulomatosis masquerading as left atrial myxoma

797

Cardiac Whipple’s disease without digestive symptoms

798

Cardiac Xenotransplantation

799

Cardiac xenotransplantation: clinical experience and future direction

800

Cardiac, pancreatic, and liver abnormalities in a patient with coxsackie-B infection

801

Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy

802

Cardiac-Directed Expression of Adenylyl Cyclase VI Facilitates Atrioventricular Nodal Conduction Original Research Article

803

Cardiac-induced physiologic noise in tissue is a direct observation of cardiac-induced fluctuations

804

Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α

805

Cardiac-specific and ligand-inducible target gene expression in transgenic mice

806

Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction

807

Cardiac-specific Gene Expression: a HANDful of Factors

808

Cardiac-specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction

809

Cardiac-specific Overexpression of Calsequestrin Results in Left Ventricular Hypertrophy, Depressed Force–frequency Relation and Pulsus Alternans In Vivo

810

Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect

811

Cardiac-specific overexpression of Gαq alters excitation–contraction coupling in isolated cardiac myocytes

812

Cardiac-specific overexpression of NCX1.1 mutant induces dilated cardiomyopathy in mice

813

Cardiac-specific Overexpression ofα1BAR RegulatesβAR Activity Via Molecular Crosstalk

814

Cardiac-synchronized gadolinium-enhanced MR angiography: preliminary experience for the evaluation of the thoracic aorta

815

Cardiac-triggered and segmented two-dimensional mr angiography of peripheral arterial occlusive disease: A pictorial essay

816

Cardiacα-adrenergic Receptor Expression is Regulated by Thyroid Hormone During a Critical Developmental Period

817

CARDINAL ARITHMETIC IN THE STYLE OF BARON VON MU¨ NCHHAUSEN

818

Cardinal B-spline dictionaries on a compact interval

819

Cardinal characteristics and projective wellorders

820

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

821

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

822

Cardinal characteristics for Menger-bounded subgroups

823

Cardinal directions between spatial objects: the pairwise-consistency problem

824

Cardinal Exponential Splines: Part II—Think Analog, Act Digital.

825

Cardinal Exponential Splines: Part I—Theory and Filtering Algorithms.

826

Cardinal functions of Pixley–Roy hyperspaces

827

Cardinal Interpolating Multiresolutions Original Research Article

828

Cardinal interpolation with polysplines on annuli Original Research Article

829

Cardinal invariants about shrinkability of unbounded sets

830

Cardinal invariants above the continuum Original Research Article

831

Cardinal invariants and -factorizability in paratopological groups

832

Cardinal invariants and independence results in the poset of precompact group topologies Original Research Article

833

Cardinal invariants in locally -minimal paratopological groups

834

Cardinal invariants of monotonically normal spaces

835

Cardinal invariants of the continuum and combinatorics on uncountable cardinals

836

Cardinal invariants related to permutation groups

837

Cardinal limits: Evidence from language awareness and bilingualism for developing concepts of number

838

Cardinal numbers associated with dense pseudocompact, countably compact, and ω-bounded subgroups

839

Cardinal sequences

840

Cardinal sequences of LCS spaces under GCH

841

Cardinal Series Interpolation to Nonuniform Grids Original Research Article

842

Cardinal temperatures for germination of Kochia scoparia (L.)

843

Cardinal transfer properties in extender models

844

Cardinal vein isomerism: An embryological hypothesis to explain a persistent left superior vena cava draining into the roof of the left atrium in the absence of coronary sinus and atrial septal defect

845

Cardinalities in depth: a formal approach to partial validation of conceptual schema

846

Cardinalities of ccc-spaces with regular -diagonals

847

Cardinalities of k-distance sets in Minkowski spaces Original Research Article

848

Cardinalities of some Lindelöf and ω1-Lindelöf T1/T2-spaces

849

Cardinality and the borda score

850

Cardinality Approach to Fuzzy Number Arithmetic

851

Cardinality bounds for subdirectly irreducible algebras Original Research Article

852

Cardinality concepts for type-two fuzzy sets

853

Cardinality constrained Boolean quadratic polytope Original Research Article

854

Cardinality constrained minimum cut problems: complexity and algorithms Original Research Article

855

Cardinality, quantifiers, and the aggregation of fuzzy criteria

856

Cardinality-restricted chains and antichains in partially ordered sets Original Research Article

857

Cardio Navigation: Planning, Simulation, and Augmented Reality in Robotic Assisted Endoscopic Bypass Grafting

858

Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats

859

Cardioactive steroid poisoning from an herbal cleansing preparation

860

Cardioameliorative effect of punicalagin against streptozotocin-induced apoptosis, redox imbalance, metabolic changes and inflammation

861

Cardio-ankle vascular index may be an important marker of silnt neuronal injury after percutaneous coronary angiography and intervention: a prospective observational study on diagnostic accuracy

862

Cardiobacterium hominis endocarditis presenting as acute embolic stroke: A case report and review of the literature

863

Cardiocerebral Resuscitation for Cardiac Arrest

864

Cardiocerebral Resuscitation Improves Survival of Patients with Out-of-Hospital Cardiac Arrest

865

Cardiocerebral Resuscitation: A Broader Perspective

866

Cardiocerebral resuscitation: advances in cardiac arrest resuscitation

867

Cardio-cerebrovascular complications in elderly with diabetes

868

Cardio-Cerebrovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Coronary Artery Disease (from the Kyoto Heart Study)

869

Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy

870

Cardiodepressant Effects of Interferon-γand Endotoxin Reversed by Inhibition of NO Synthase 2 in Rat Myocardium

871

Cardiodepressive Mediators Are Released After Ischemi From an Isolated Heart: Role of Coronary Endothelial Cells

872

Cardioembolic Source of ST-Segment Elevation Myocardial Infarction

873

Cardioembolic Stroke

874

Cardioembolic stroke: an update

875

Cardioesophageal reflex: mechanism for “linked angina” in patients with angiographically proven coronary artery disease

876

Cardio-facio-cutaneous syndrome and moyamoya syndrome

877

Cardiogel as an Instructive Microenvironment for in vitro Differentiation of Bone Marrow Derived Mesenchymal Stem Cells into Cardiomyocytes

878

Cardiogenic and Aortogenic Brain Embolism Review Article

879

Cardiogenic shock

880

Cardiogenic shock

881

Cardiogenic Shock and Anterior Papillary Muscle Rupture Caused by Blood Supply to Diagonal Artery

882

cardiogenic shock and anterior papillary muscle rupture caused by blood supply to diagonal artery

883

Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: Related factors

884

Cardiogenic shock caused by right ventricular infarction: A report from the SHOCK registry

885

Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents

886

Cardiogenic shock complicating acute carbon monoxide poisoning despite neurologic and metabolic recovery

887

Cardiogenic shock complicating acute coronary syndromes

888

Cardiogenic shock complicating acute myocardial infarction in California: effect of invasive procedures on mortality

889

Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival?

890

Cardiogenic shock complicating acute myocardial infarction: Predictors of death

891

Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry

892

Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry

893

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry

894

Cardiogenic shock due to coronary narrowings one day after a MAZE III procedure

895

Cardiogenic shock due to myocardial infarction caused by coronary vasospasm associated with hyperthyroidism

896

Cardiogenic Shock due to Psychosis-Induced Inverted Takotsubo Cardiomyopathy Bridged-to-Recovery with a Percutaneous Left Ventricular Assist Device

897

Cardiogenic shock following electro-cardioversion of new onset atrial flutter

898

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

899

CARDIOGENIC SHOCK IN ADULT PATIENTS WITH NON-ST ELEVATION MYOCARDIAL INFARCTION

900

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry

901

Cardiogenic Shock Without Flow-Limiting Angiographic Coronary Artery Disease—(from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry)

902

Cardiogenic shock: Basics and clinical considerations

903

Cardiogenic Shock: Collaboration Between Cardiac Surgery and Cardiology Subspecialties to Bridge to Recovery

904

Cardiogenic shock: is there light at the end of the tunnel?

905

Cardiographic conundrum: Adding insult to injury

906

Cardiohepatic Interactions in Heart Failure: An Overview and Clinical Implications

907

Cardioinhibitory syncope due to bloodphobia associated asystole

908

Cardiolinka bohemica (Barrande, 1881) – A first representative of the Late Silurian Bohemian type Bivalvia fauna from the northern Arabian Plate, Southeast Turkey

909

Cardiolipin Clusters and Membrane Domain Formation Induced by Mitochondrial Proteins

910

Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis

911

Cardiolipin Enhances Protein C Pathway Anticoagulant Activity,

912

Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication

913

Cardiological applications of nuclear medicine Review Article

914

Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome

915

Cardiologist Concordance With the American College of Cardiology Appropriate Use Criteria for Cardiac Testing in Patients With Coronary Artery Disease

916

Cardiologist in the carotids

917

Cardiologist in the dugout

918

Cardiologist in the Land of the Thunder Dragon: A Medical Mission to Bhutan

919

Cardiologist on trial: reflections on credible evidence

920

Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes

921

Cardiologist’s Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

922

Cardiologists Knowledge and Attitudes About Methadone and Buprenorphine Maintenance Treatment: A Survey Study in Tehran, Iran

923

Cardiologistsʹ discussions about sexuality with patients with chronic coronary artery disease

924

Cardiologists in casualty?

925

Cardiologistsʹ knowledge of the 2005 American Heart Association Resuscitation Guidelines: The Athens Study

926

Cardiologistsʹ practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction

927

Cardiologists recommend Fragmin

928

Cardiologists versus internists in the care of unstable angin

929

Cardiologists, the PINNACLE Registry, and the “Meaningful Use” of Electronic Health Records

930

Cardiologists’ Knowledge and Perception towards American Heart Association Guidelines of Cardiopulmonary Resuscitation; a Letter to Editor

931

Cardiologists’ Perception of Risk of Coronary Revascularization Procedures

932

Cardiology 2010, 13th Annual Update on Pediatric Cardiovascular Disease: Abstracts

933

Cardiology and emergency medicine: United We Stand, divided we fall

934

Cardiology and neurologic family screening in noncompaction

935

Cardiology and the Critical Care Crisis: A Perspective Review Article

936

Cardiology in a Flat World

937

Cardiology in cattle: Knowledge and expertise are the sine qua non for optimal economic medicine

938

Cardiology in contemporary China: An update

939

Cardiology in India

940

Cardiology in India: State of the Art or Straight off the Heart?

941

Cardiology in South America

942

Cardiology Integration: Challenge and Opportunity

943

Cardiology management improves secondary prevention measures among patients with coronary artery disease Original Research Article

944

Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting

945

Cardiology rounds

946

Cardiology screening on the net

947

Cardiology Workforce Crisis: Shortage or Surplus?

948

Cardiology Workforce Revisited

949

Cardiology workforce: there’s already a shortage, and it’s getting worse!

950

Cardiology, for what itʹs worth

951

Cardiology: “Itʹs small world after all”

952

Cardiology: a call for papers

953

Cardiology: American Journal of Medicine theme issue

954

Cardiology: call for papers

955

Cardiology: the past, the present, and the future

956

Cardiology: where to go from here?

957

Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure

958

Cardiomegaly in a young infant

959

Cardiometabolic Abnormalities in Current National Football League Players

960

Cardiometabolic Consequences of Gestational Dysglycemia

961

Cardiometabolic Risk and Cognitive Function Decline in U.S. Elderly

962

Cardiometabolic Risk Factors in Fructose-Induced Insulin Resistant Rats: Comparative Effects of Palm and Olive Oils

963

Cardio-metabolic risk factors in Iranian children: where we are and the others?

964

Cardiometabolic risk factors in polycystic ovary syndrome

965

Cardiomodulating Activity of Gongronema latifolium and Lisinopril in Doxorubicin-induced Cardiotoxicity in Wistar Rats

966

Cardiomyocyte Apoptosis After Antegrade and Retrograde Cardioplegia

967

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations

968

Cardiomyocyte apoptosis in cocaine-induced myocarditis with involvement of bundle of His and left bundle branch

969

Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis

970

Cardiomyocyte death and renewal in the normal and diseased heart

971

Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies

972

Cardiomyocyte Hypertrophy, Oncosis, and Autophagic Vacuolization Predict Mortality in Idiopathic Dilated Cardiomyopathy With Advanced Heart Failure

973

Cardiomyocyte Injury Assessed by a Highly Sensitive Troponin Assay and Sudden Cardiac Death in the Community: The Cardiovascular Health Study

974

Cardiomyocyte Marker Expression in Mouse Embryonic Fibroblasts by Cell-Free Cardiomyocyte Extract and Epigenetic Manipulation

975

Cardiomyocyte Mitochondrial Dynamics in Health and Disease and the Role of Exercise Training: A Brief Review

976

Cardiomyocyte proteome 2-D gel database construction: Detection and identification of co-migrating proteins

977

Cardiomyocyte Resistance to Doxorubicin Mediated by A3 Adenosine Receptor

978

Cardiomyocyte resistance to doxorubicin toxicity may be achieved by adenosine signaling

979

Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction

980

Cardiomyocyte Transplantation Improves Heart Function

981

Cardiomyocyte-restricted deletion of connexin43 during mouse development

982

Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities

983

Cardiomyocytes morphologic and metabolic response to angiotensin II is mediated by NFκB-induced inactivation of PPAR isoforms

984

Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium

985

Cardiomyocytes β-adrenergic receptors are resistants to short-term desensitization

986

Cardiomyocyte-Specific Deletion of Gsk3α Mitigates Post–Myocardial Infarction Remodeling, Contractile Dysfunction, and Heart Failure

987

Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement

988

Cardiomyocyte-targeted siRNA delivery by prostaglandin E2-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis

989

Cardiomyogenic potential of skeletal muscle-derived progenitor cells

990

Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis

991

Cardiomyopathic lentiginosis: an echo-Doppler report

992

Cardiomyopathies: from genetics to the prospect of treatment

993

CARDIOMYOPATHIES: PRESENTATION AND COMPLICATIONS IN CHILDREN AT DERA ISMAIL KHAN

994

Cardiomyopathy and Myopathy in Left Ventricular Noncompaction

995

Cardiomyopathy Due to Nonsustained Ventricular Tachycardia Originating from the Aortic Sinus Cusp

996

Cardiomyopathy in a Male with Cystinosis

997

Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine

998

Cardiomyopathy in Danish patients with coeliac disease

999

Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect

1000

Cardiomyopathy in neurological disorders

بازگشت